Related Experiment Video
Updated: Jul 2, 2026
09:54
Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
Published on: August 10, 2012
FMRP acts as a key messenger for dopamine modulation in the forebrain
Hansen Wang1, Long-Jun Wu, Susan S Kim
1Department of Physiology, Faculty of Medicine, University of Toronto, 1 King's College Circle, Toronto, ON M5S1A8, Canada.
Neuron
|September 2, 2008
Summary
Fragile X mental retardation protein (FMRP) impacts dopamine signaling and synaptic plasticity. Targeting G protein-coupled receptor kinase 2 (GRK2) with drugs can restore dopamine receptor function in fragile X syndrome models.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Fragile X mental retardation protein (FMRP) is crucial for regulating translation and synaptic plasticity.
- Dopamine (DA) signaling plays a vital role in synaptic potentiation and cognitive functions.
Purpose of the Study:
- To investigate the role of FMRP in dopamine modulation of synaptic potentiation.
- To elucidate the molecular mechanisms underlying D1 receptor dysfunction in fragile X syndrome.
Main Methods:
- Primary neuronal cultures from Fmr1(-/-) mice.
- Western blotting and immunohistochemistry.
- Pharmacological interventions targeting GRK2.
- Behavioral tests in Fmr1(-/-) mice.
Main Results:
- FMRP deficiency impairs D1 receptor-mediated potentiation of AMPA receptor surface expression and phosphorylation.
- D1 receptor signaling is disrupted in Fmr1(-/-) mice due to hyperphosphorylation and GRK2 redistribution.
- FMRP interacts with GRK2, and GRK2 inhibition rescues D1 receptor signaling.
- D1 receptor agonist treatment ameliorates hyperactivity and motor deficits in Fmr1(-/-) mice.
Conclusions:
- FMRP is essential for proper dopamine modulation of synaptic function in the forebrain.
- Dysregulation of the FMRP-GRK2-D1 receptor pathway contributes to fragile X syndrome pathophysiology.
- Targeting GRK2 may offer a therapeutic strategy for fragile X syndrome.
Related Concept Videos
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:23Role of Neurotransmitters in Memory
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...
01:26Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
01:25Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
01:30Regulation of Food Intake
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...